Vasundhara Rasayans
158.35
-3.20(-1.98%)
Market Cap₹50.28 Cr
PE Ratio13.52
IndustryHealthcare
Company Performance:
1D-1.98%
1M+22.47%
6M-19.88%
1Y-23.78%
5Y+68.64%
View Company Insightsright
More news about Vasundhara Rasayans
06Sept 25
Vasundhara Rasayans Declares Rs. 2 Per Share Dividend, Appoints New Directors
Vasundhara Rasayans Limited has announced a dividend of Rs. 2.00 per equity share. The company appointed Shri Ashok Kumar Jain as Additional Independent Director and Shri Kodakandla Sidarsanam as additional Whole-time Director. The 37th Annual General Meeting (AGM) is scheduled with book closure from September 24-30 and a cut-off date of September 23 for e-voting and dividend eligibility. Mrs. Rakhi Agarwal has been appointed as the e-voting Scrutinizer for the AGM.
 no imag found
13Aug 25
Vasundhara Rasayans Reports Q1 Net Profit of ₹57.28 Crore, Down 33.5% Year-on-Year
Vasundhara Rasayans Limited announced Q1 financial results, showing a 2.08% increase in total income to ₹824.50 lakh, but a 33.51% decrease in net profit to ₹57.28 lakh. Net sales slightly decreased by 0.90% to ₹756.15 lakh. Total expenses rose by 8.08% to ₹747.10 lakh, primarily due to increased finance costs and other expenses. Earnings per share dropped from ₹2.71 to ₹1.80. The company operates in the agri products segment.
 no imag found
Vasundhara Rasayans
158.35
-3.20
(-1.98%)
1 Year Returns:-23.78%
Industry Peers
Sun Pharmaceutical
1,788.50
(-0.08%)
Divis Laboratories
6,576.50
(+0.67%)
Torrent Pharmaceuticals
4,368.50
(+1.17%)
Cipla
1,375.20
(-0.30%)
Zydus Life Science
1,076.60
(-0.16%)
Dr Reddys Laboratories
1,263.30
(-0.84%)
Lupin
2,261.20
(+0.51%)
Mankind Pharma
2,369.50
(+3.07%)
Aurobindo Pharma
1,440.40
(+0.78%)
Laurus Labs
1,394.30
(+0.85%)